ARTICLE | Politics, Policy & Law
SEC filings disclose potential negative impacts of Biosecure Act
By Steve Usdin, Washington Editor
March 29, 2024 10:11 PM UTC
While almost every major pharmaceutical company would be directly affected if Congress enacts legislation restricting access to the services of Chinese contract research and manufacturing companies, the biggest impacts are likely to be felt by small biotechs.
Virtually every large pharma company works with a Chinese CDMO, but none are as reliant on companies such as WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) and WuXi Biologics Inc. (HKEX:2269) as companies that lack their own manufacturing capabilities. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651939/small-biotechs-reveal-reliance-on-chinese-cdmos